Clinical trial
N-Acetylcysteine Role on Urinary KIM-1 and Serum Creatinine Level in Cancer Patient With Cisplatin Based Chemotherapy
NCT07156786 is registered in ClinicalTrials.gov with Fakultas Kedokteran Universitas Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- N-Acetylcysteine Role on Urinary KIM-1 and Serum Creatinine Level in Cancer Patient With Cisplatin Based Chemotherapy
- Lead sponsor
- Fakultas Kedokteran Universitas Indonesia
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- September 15, 2025
- Completion date
- August 31, 2027
- Enrollment
- 72 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acetylcysteine adverse reaction, acute kidney injury, cancer (solid tumors), kidney function issue, kidney function tests